The Town of Apex (“The Town”) is seeking proposals from qualified weight management vendors who can integrate GLP-1 receptor agonist medications (e.g., Wegovy, Zepbound) with lifestyle coaching to manage obesity and related conditions.
The Town’s objectives in conducting this evaluation are: 1) to continue to provide access for plan members to GLP-1 medications for the treatment of obesity, 2) require engagement in a weight management program to encourage lifestyle and behavioral changes 3) lower Town expense related to GLP-1 medications for the treatment of obesity.
Coverage for weight loss GLP-1 medications are currently covered under the group health plan. However, the Town is considering excluding the medication from the group health plan should they partner with a standalone weight management and GLP-1 vendor.